R3TA

Reta is a triple agonist peptide targeting GIP, GLP-1, and glucagon receptors. Each vial contains 30mg of lyophilized powder for reconstitution.

• Triple receptor agonist (GIP/GLP-1/Glucagon)
• 30mg per vial
• Lyophilized powder — requires reconstitution with bacteriostatic water
• Store in a cool, dry place away from light

Potential research areas: Appetite regulation, body weight, glucose metabolism, insulin sensitivity, energy expenditure, lipid metabolism, liver fat, and overall cardiometabolic function. For research use only.

These are the main areas Retatrutide has been investigated for:

• Weight management
• Appetite suppression
• Blood glucose regulation
• Insulin sensitivity
• Increased energy expenditure
• Fat metabolism
• Liver fat reduction
• Cardiometabolic health
• Metabolic dysfunction–associated liver disease (MASLD)